In her closing thoughts, Dr Michos highlights social determinants of health impacting the treatment landscape for patients with cardiovascular disease.
ACC.23 Annual Scientific Session and Expo Together with the World Congress of Cardiology (WCC) 2023
A medical expert discusses preauthorization requests and requirements for cardiovascular disease treatment, commenting on an abstract presented at the ACC 2023 Annual Scientific Session and Expo and World Congress of Cardiology.
Dr Michos examines a controlled trial focusing on co-payment elimination and its effects on cardiovascular outcomes for low-income adults.
Hypercholesterolemia impact on cardiovascular outcomes is explored by a key opinion leader.
Dr Michos offers strategies to successfully reduce LDL levels in patients with cardiovascular disease.
Erin Michos, MD, MHS, opens a discussion surrounding the utilization of bempedoic acid for patients with intolerance to statin-based therapies.
Advertisement
Advertisement
Trending on AJMC
1
Government Shutdown Could Disrupt Health Care Access
2
Most Medicare Beneficiaries Find Plan Shopping Confusing, Survey Finds
3
Maternal, Child Mortality Higher in the US Compared With Majority of High-Income Countries
4
Lurbinectedin Combo Approved by FDA for Extensive-Stage Small Cell Lung Cancer
5
